2-amino-2-hydroxymethyl-3,4-dihydroxy-14- oxoeicos-6-enoic acid,
ISP-1 serine palmitoyltransferase inhibitor,
ISP-1 suppressant,
myriocin,
SPI-1 inhibitor,
thermozymocidin,
Myriocin,
thermozymocidin,
35891-70-4,
ISP-I,
ISP-1,
UNII-YRM4E8R9ST,
(2S,3R,4R,6E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid,
YRM4E8R9ST,
Myriocin, Mycelia sterilia,
Myriocin from Mycelia sterilia,
CHEBI:582124,
NCGC00163597-02,
NCGC00163597-03,
(2S,3R,4R,6E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid,
DSSTox_CID_26360,
DSSTox_RID_81561,
DSSTox_GSID_46360,
(E,2S,3R,4R)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid,
[2S,3R,4R]-(E)-2-Amino-3,4-dihydroxy-2-[hydroxymethyl]-14-oxo-6-eicosenoic Acid,
6-Eicosenoic acid, 2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-, (2S-(2R*,3S*,4S*,6E))-,
CAS-35891-70-4,
SR-05000002333,
C21H39NO6,
antibiotic ISP-I,
(+)-Myriocin,
Myriocin,mycella sterilia,
AC1O5PM5,
CHEMBL55076,
GTPL6664,
SCHEMBL6542261,
SCHEMBL8499386,
DTXSID9046360,
BIM1005,
ZX-AFC000311,
HMS3649I03,
ZINC5782527,
Tox21_112062,
Tox21_113400,
1865AH,
LMFA01060203,
MFCD01632772,
AKOS030568046,
Tox21_112062_1,
CCG-208239,
NSC 177379,
NCGC00163597-01,
NCGC00163597-04,
LS-63800,
LS-185036,
C19914,
SR-05000002333-2,
SR-05000002333-3,
Myriocin from Mycelia sterilia, >=98% (HPLC), powder,
(2S,3R,4R)-(E)-2-Amino-3,4-dihydroxy-2-hydroxymethyl-14-oxoeicos-6-enoic Acid,
(2S,3R,4R,E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid,
[2S-(2R*,3S*,4S*,6E)]-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic Acid,
SPI-1 inhibitor,
ISP-1 suppressant,
D07MQF,
Myriocin from |Mycelia sterilia|,
C21-H39-N-O6,
CID6438394,
ISP-1 serine palmitoyltransferase inhibitor,
C001996,
Myriocin, 99%, from Mycelia sterilia - 5MG 5mg,
2-amino-2-hydroxymethyl-3,4-dihydroxy-14- oxoeicos-6-enoic acid,